- Generic name
- Methyl Prednisolone
- Strength
- 4 mg
- Dosage form
- Tablet
- Manufactured by
- Nuvista Pharma Ltd
Prednis 4 Tablet
About Prednis 4 Tablet
Prednis 4 is a tablet made by Nuvista Pharma Ltd. It contains 4 mg of methyl prednisolone, a glucocorticoid medicine. Doctors prescribe it for certain endocrine and rheumatic conditions.
There are 22 brands of Methyl Prednisolone listed in Bangladesh. The lowest listed price is Depodrol 2 mg Tablet at ৳ 3 per unit.
What is Prednis 4 Tablet?
Prednis 4 is a tablet from Nuvista Pharma Ltd that contains 4 mg of methyl prednisolone. Methyl prednisolone belongs to a group of medicines called glucocorticoids, which are related to hormones the body makes naturally. It is used in conditions such as primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis, hypercalcemia linked to cancer, and several rheumatic disorders including rheumatoid arthritis and juvenile rheumatoid arthritis. It also has anti-inflammatory and immune-suppressing effects. Because it is a steroid medicine, it should only be taken when a doctor prescribes it, and the doctor decides the dose and course.
Uses of Prednis 4
Prednis 4 is used for endocrine disorders such as primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis and hypercalcemia associated with cancer. It is also used for rheumatic disorders including rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute and subacute bursitis, synovitis of osteoarthritis and acute nonspecific tenosynovitis. It works as an anti-inflammatory and immune-suppressing medicine. Your doctor will decide whether it is suitable for your condition.
How to use Prednis 4
Prednis 4 is a tablet and should be taken exactly as your doctor tells you. The doctor decides the dose and how long you take it. Do not change the dose or stop suddenly on your own, because stopping a glucocorticoid suddenly can cause problems. If you miss a dose, ask your doctor or pharmacist what to do. Tell your doctor about all other medicines you take, since some medicines can interact with methyl prednisolone. Keep the tablet in a cool, dry place away from light and out of reach of children.
Side effects of Prednis 4
Short courses of methyl prednisolone are usually well tolerated with few, mild side effects. Long-term use at high doses may cause more serious side effects. Reported side effects include fluid retention, weight gain, high blood pressure, potassium loss, headache, muscle weakness and increased hair growth. Call your doctor if you notice any side effect that worries you, if it does not go away, or if you feel unwell. Ask your doctor or pharmacist about anything you are unsure of.
Safety and precautions
Prednis 4 is not suitable for everyone. Do not take it if you have a systemic fungal infection or are allergic to any of its ingredients. Tell your doctor before starting if you are pregnant, planning pregnancy or breastfeeding, because methyl prednisolone is pregnancy category C and should be used only if the benefit justifies the risk to the foetus. It has not been adequately evaluated in nursing mothers. Ask your doctor first if you have thyroid problems, cirrhosis, ocular herpes simplex, or if you take blood thinners or other medicines. The doctor decides the dose and course.
Frequently asked questions
What does the generic name methyl prednisolone mean?
Methyl prednisolone is the generic name of the active ingredient in Prednis 4. It is a glucocorticoid, a type of steroid hormone medicine that reduces inflammation and suppresses the immune system. The brand Prednis 4 from Nuvista Pharma Ltd contains this same active ingredient at a strength of 4 mg in tablet form.
What is Prednis 4 used for and what kind of medicine is it?
Prednis 4 is a glucocorticoid tablet used for certain endocrine disorders and rheumatic conditions, including rheumatoid arthritis and adrenocortical insufficiency. It reduces inflammation and suppresses the immune system. It is a prescription medicine, so your doctor will decide if it is right for you and will set the dose and course.
What side effects should I watch for and when should I call the doctor?
Side effects can include fluid retention, weight gain, high blood pressure, potassium loss, headache, muscle weakness and increased hair growth. Short courses are usually well tolerated, but long-term high doses may cause serious effects. Call your doctor if any side effect worries you, does not go away, or if you feel unwell.
Can I stop taking Prednis 4 on my own?
No. Do not stop taking Prednis 4 suddenly without talking to your doctor. Glucocorticoid medicines like this one need to be reduced gradually in some cases, and stopping on your own can cause problems. Always follow your doctor's instructions about how long to take it and how to stop.
Indications
Rheumatic Disorders: Rheumatoid Arthritis. Juvenile Rheumatoid Arthritis, Ankylosing ... Read moreEndocrine Disorders: Primary or Secondary Adrenocortical Insufficiency, Congenital Adrenal Hyperplasia, Nonsuppurative Thyroiditis, Hypercalcemia associated with Cancer.
Rheumatic Disorders: Rheumatoid Arthritis. Juvenile Rheumatoid Arthritis, Ankylosing Spondylitis, Acute and Subacute Bursitis, Synovitis of Osteoarthritis, Acute nonspecific Tenosynovitis, Post-traumatic Osteoarthritis, Psoriatic Arthritis, Epicondylitis, Acute Gouty Arthritis.
Collagen Diseases: Systemic lupus Erythematosus, Systemic Dermatomyositis and Acute Rheumatic Carditis.
Dermatologic Diseases: Bullous Dermatitis Herpetiformis, Severe Erythema Multiforme (Stevens-Johnson syndrome), Severe Seborrheic Dermatitis, Exfoliative Dermatitis, Mycosis Fungoides, Pemphigus, Severe Psoriasis.
Allergy: Seasonal or Perennial Allergic Rhinitis, Drug hypersensitivity reactions, Serum Sickness, Contact Dermatitis, Bronchial Asthma and Atopic Dermatitis;
Ophthalmic Diseases: Allergic Corneal Ulcers, Herpes Zoster Ophthalmicus, Anterior segment inflammation, Sympathetic Ophthalmia, Keratitis, Optic Neuritis, Allergic Conjunctivitis, Chorioretinitis, iritis end iridocyclitis.
Respiratory Diseases: Symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, Aspiration Pneumonitis.
Hematological Disorders: Idiopathic Thrombocytopenic Purpura in adults, Secondary Thrombocytopenia in adults, Acquired (Autoimmune) Hemolytic Anemia, Erythroblastopenia, Congenital (Erythroid) Hypoplastic Anemia.
Neoplastic Diseases: For palliative management of Leukemias and Lymphomas in adults, Acute leukemia of childhood.
Edematous States: To induce a diuresis or remission of Proteinuria in the Nephrotic Syndrome, without Uremia, of the idiopathic type or that due to Lupus Erythematosus.
Gastrointestinal Disease: To tide the patient over a critical period of the disease in Ulcerative Colitis & Regional Enteritis.
CNS Disease: Acute Exacerbations of Multiple Sclerosis.
Pharmacology
protein, and carbohydrate metabolism, skeletal muscle, the cardiovascular system, the immune system, the nervous system, and the endocrine system.
Pharmacokinetic properties: The absolute bioavailability of Methylprednisclone is generally high (82% to 89%) following oral administration and rapidly absorbed and the maximum plasma concentration is achieved around 1.5 to 2.3 hours across doses following oral administration in normal healthy adults. Methylprednisolone is widely distributed into the tissues and its volume of distribution is 41-61.5 liter. It crosses the Wood-brain barrier and the placental barrier and is secreted in breast milk. The plasma protein binding of Methylprednisolone in humans is approximately 77%. Methylprednisolone is metabolized in the liver to inactive metabolites. No dosing adjustments are necessary for renal failure. Methylprednisolone is haemodializable.
Dosage & Administration
As anti-inflammatory or immunosuppressive initial dosage: As anti-inflammatory or immunosuppressive, the initial dosage of Methylprednisolone tablets may vary from 4-48 mg per day depending on the specific disease entity being treated, in situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time there is a lack of satisfactory dirtied response, Methylprednisolone should be discontinued and the patient transferred to other appropriate therapy. It should be emphasized that dosage requirements are variable and must be Individualized on the basis of the disease under treatment and the response of the patient.
As anti-inflammatory or immunosuppressive maintenance dosage: After a favorable response is noted, the proper maintenance dosage should be determined by decreasing the initial drug dosage in small decrements at appropriate time intervals until the lowest dosage which will maintain an adequate clinical response is reached. It should be kept in mind that constant monitoring is needed in regard to drug dosage. If after long-term therapy the drug is to be stopped, it is recommended that it be withdrawn gradually rather than abruptly.
Multiple Sclerosis: In the treatment of acute exacerbations of multiple sclerosis, daily doses of 160 mg of Methylprednisolone for a week followed by 64 mg every other day for 1 month have been shown to be effective.
Methylprednisolone 4 mg tablet can be used to treat and to control severe allergy end dermatitis following the guideline listed below to minimize the steroid withdrawal syndromes:
- Day 1: 2 tablets before breakfast + 1 tablet after lunch + 1 tablet after dinner + 2 tablets at bedtime
- Day 2: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet after dinner + 2 tablets at bedtime
- Day 3: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet after dinner + 1 tablet at bedtime
- Day 4: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet at bedtime
- Day 5: 1 tablet before breakfast + 1 tablet at bedtime
- Day 6: 1 tablet before breakfast
The following should be kept in mind when considering alternate-day therapy:
- Basic principles and indications for corticosteroid therapy should be applied.
- Alternate-day therapy is a therapeutic technique primarily designed for pefienis in whom long-term pharmacologic corticoid therapy is anticipated.
- In less severe disease processes in which corticoid therapy is indicated, it may be possible to initiate treatment with alternate-day therapy. More severe disease state usually will require daily divided high dose therapy for initiai control of the disease process. The initial suppressive dose level should be continued until a satisfactory clinical response is obtained, usually four to ten days in the case of many allergic and collagen diseases.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Storage Conditions
Alternative brands of Methyl Prednisolone
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.